Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis
- 1 May 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (5), 1404-1409
- https://doi.org/10.1161/01.atv.20.5.1404
Abstract
—Hormone replacement therapy (HRT) appears to be cardioprotective in postmenopausal women; however, concerns exist over its thrombogenic effects. To address the effects of combined HRT on c...Keywords
This publication has 35 references indexed in Scilit:
- EditorialCardiovascular Research, 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- EFFECTS OF ESTROGEN REPLACEMENT THERAPY ON THROMBIN GENERATIONThrombosis Research, 1997
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Risk of venous thromboembolism in users of hormone replacement therapyThe Lancet, 1996
- The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal statusAmerican Journal of Obstetrics and Gynecology, 1995
- Haemostatic changes during continuous oestradiolprogestogen treatment of postmenopausal womenBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseNew England Journal of Medicine, 1985